Lapatinib inhibited Walker 256 rat breast tumour cell proliferation but with lower cytotoxic effect, which could be due to lower ErbB2 mRNA with ErbB1 mRNA was not able to be detected in the cells. This evidence concerns the gene ERBB2 and breast neoplasm.